Vimarsana
Biggest News Aggregation in the World

Ig Ivig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ig Ivig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ig Ivig Today - Breaking & Trending Today

First Treatment in 30 Years for Rare Disease Safe, Effective - Vimarsana News

First Treatment in 30 Years for Rare Disease Safe, Effective

Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.

Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026 - KORU Medical Systems (NASDAQ:KRMD) - Vimarsana News

Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026 - KORU Medical Systems (NASDAQ:KRMD)

B.

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19 | Virology Journal - Vimarsana News

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19 | Virology Journal

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19), which is currently a worldwide pandemic. There are limited available treatments for severe COVID-19 patients. However, some evidence suggests that intravenous immunoglobulin (IVIg) provides clinical benefits for these patients. We administered IVIg to 23 severe COVID-19 patients, and all of them survived. Four related coronaviruses can cause the common cold. We speculated that cross-reactivity of SARS-CoV-2 and other common coronaviruses might partially explain the clinical eff...